Regulatory Comments/Rulings |
|
National Patient Advocate Foundation actively supports regulatory proposals that improve access to healthcare. As part of its Federal Government Affairs Program, NPAF submits comments to Regulatory Agencies, including the Food and Drug Administration (FDA) and the Department of Health and Human Services (DHHS), in an effort to incorporate the patient voice in regulatory decisions. Comments to CMSNPAF Comments Re: Proposed Revisions to the Medicare Advantage and Prescription Drug Benefit Programs in CMS-4131-P [7/15/2008] View Comments NPAF Comments Re: Proposed Changes to Medicare Programs Hospital Inpatient Prospective Payment System [6/13/2008] View Comments NPAF Comments Re: CMS Coverage for PET [5/10/2008] View Comments NPAF Comments Re: Proposed Rulemaking on Patient Safety and Quality Improvement [4/4/2008] View Comments NPAF Comments Re: Contract Year 2009 Draft Call Letter [1/31/2008] View Comments NPAF Comments Re: Proposed Standards for E-Prescribing Under Medicare Part D [1/15/2008] View Comments NPAF Comments Re: Proposed Changes to the Hospital Outpatient Prospective Payment System (HOPPS) and CY 2008 Payment Rates [9/14/2007] View Comments NPAF Comments Re: Revisions to Payment Policies under the Physician Fee Schedule [8/31/2007] View Comments NPAF Comments Re: Proposed Decision Memorandum for Medicare National Clinical Trial Policy [8/17/2007] View Comments NPAF Letter to The Honorable Michael O. Leavitt, Secretary of Health and Human Services, Re: Final Decision on ESAs; patient access remains too restricted [8/3/2007] View Complete Letter NPAF Letter to The Honorable Michael O. Leavitt, Secretary of Health and Human Services, Re: Medicare Evidence Development and Coverage Advisory Committee Recommendations [6/25/2007] View Complete Letter NPAF Comments Re: Proposed Decision for Erythropoiesis Stimulating Agents (ESAs) for Non-Renal Disease Indications [5/31/2007] View Comments NPAF Comments Re: Proposed Decision Memorandum on Clinical Trial Policy [5/10/2007] View Comments NPAF Comments Re: Draft 2008 Call Letter [4/3/2007] View Comments NPAF Comments Re: Removal of Iron Overload Agents Class in final Medicare Model Guidelines Version 3.0 [3/28/2007] View Comments Comments to FDALetter from NPAF RE: expanded access to investigational drugs [3/17/2007] View Comments View Archived Comments |
NPAF Election Center!
Do you know where each of the Presidential candidates stands on important health care issues? Would you like to attend a candidate event and support health care access issues? Visit the NPAF Election Center for candidate information and health care proposals.
